BioCentury
ARTICLE | Finance

Analyst tracks

Biotech investor, banker and analyst personnel changes

July 22, 2013 7:00 AM UTC

Marshall Urist is joining Royalty Pharma as VP of research and investments. He previously was an executive director and senior biotechnology analyst at Morgan Stanley.

Marc Cabrera joined the healthcare investment banking group of Oppenheimer & Co. as a managing director and head of healthcare services. Cabrera was a managing director and head of healthcare at Morgan Joseph...